L
Lite Strategy, Inc. (LITS)
NCM – Real Time Price. Currency in USD
1.25
+0.01 (0.81%)
At close: May 12, 2026, 4:00 PM EDT
1.25
0.00 (0.00%)
After-hours: May 12, 2026, 6:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.25
+0.01 (0.81%)
At close: May 12, 2026, 4:00 PM EDT
1.25
0.00 (0.00%)
After-hours: May 12, 2026, 6:00 PM EDT
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
| Name | Position |
|---|---|
| Dr. Robert D. Mass M.D. | Strategic Advisor |
| Mr. Justin J. File CPA | CEO, CFO, Corporate Secretary & Director |
| Ms. Anne Frese | Chief People Officer |
| Date | Type | Document |
|---|---|---|
| 2026-02-17 | 8-K | lits-20260217.htm |
| 2026-02-17 | 10-Q | lits-20251231.htm |
| 2026-02-12 | 8-K | lits-20260212.htm |
| 2026-01-27 | DEFA14A | defa14a.htm |
| 2025-12-30 | DEF 14A | lits-20251230.htm |
| 2025-12-05 | 8-K | lits-20251202.htm |
| 2025-11-20 | 8-K/A | lits-20251114.htm |
| 2025-11-18 | 8-K | lits-20251114.htm |
| 2025-11-14 | 10-Q | lits-20250930.htm |
| 2025-10-30 | 8-K | lits-20251024.htm |